Evidence map›Paper›PMID 41917361›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Deep Protease Profiling to Define the Substrate Specificity of ADAMTS Proteases.

Rex Huang, Enoch Yu, Kaitlyn Ho, Peter Andriasani, Cherie Teney, Colin A Kretz

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rex HuangThrombosis and Atherosclerosis Research Institute, Department of Medicine, McMaster University, Hamilton, ON, Canada.
Enoch YuThrombosis and Atherosclerosis Research Institute, Department of Medicine, McMaster University, Hamilton, ON, Canada.
Kaitlyn HoThrombosis and Atherosclerosis Research Institute, Department of Medicine, McMaster University, Hamilton, ON, Canada.
Peter AndriasaniThrombosis and Atherosclerosis Research Institute, Department of Medicine, McMaster University, Hamilton, ON, Canada.
Cherie TeneyThrombosis and Atherosclerosis Research Institute, Department of Medicine, McMaster University, Hamilton, ON, Canada.
Colin A KretzThrombosis and Atherosclerosis Research Institute, Department of Medicine, McMaster University, Hamilton, ON, Canada. colin.kretz@taari.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Determining the active site specificity of proteases is critically important for defining their role in biological systems. This article outlines a method for coupling substrate phage display with high-throughput sequencing to comprehensively define the active site specificity of proteases. We call this method deep protease profiling. We apply deep protease profiling to the metalloprotease ADAMTS13, a member of the metzincin family of proteases, that helps maintain the integrity of the cardiovascular system. The only known substrate for ADAMTS13 is von Willebrand factor (VWF), a multimeric glycoprotein that recruits platelets and other immune cells to sites of vascular injury. However, our understanding of ADAMTS13 substrate specificity remains limited. Deep protease profiling of ADAMTS13 initially revealed very few significantly cleaved peptides. However, substituting the phage display library into the P3-P3' interval of VWF73, a minimal VWF substrate used to detect ADAMTS13 activity, revealed over 1600 cleaved peptides. These peptides aligned into a clear substrate recognition motif, confirming the importance of exosite engagement and providing a detailed recognition profile that may guide the identification of novel biological substrates for ADAMTS13. This method is broadly applicable to other members of the ADAMTS protease family, whose substrate specificity remains poorly characterized.

Indexed as

ADAMTS13 ProteinPeptide HydrolasesCatalytic DomainHigh-Throughput Nucleotide SequencingHumansPeptide LibraryPeptidesProteolysisSubstrate Specificityvon Willebrand FactorADAMTS13 ProteinADAMTS13 protein, humanPeptide HydrolasesPeptide LibraryPeptidesvon Willebrand FactorADAMTS13High-throughput sequencingProteolysisSpecificitySubstrate phage display

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.